Maybe we could be better than Neuren -Neu, page-7

SOI is actually a big problem.
This stock has nothing to do with the the FDA. It's TGA only. so it has minimal scope. Can it get to a MC of 500? Sure.

NEU will sell for something like 7 bill.
You want to head down the road of FDA? Fine, find 300 mil.
NTI don't have it. They'll either hand over all of the margin to a third party (like neuren did) Or the shares will quadruple.

NEU is just under a shorter attack. And it's to be expected. 90% of holders expect the company to be sold this year. So it's being accumulated.
'Glory' put up some figures. Acadia who own the rights report in 7 days. Lets see the rebuttal of all of the claims.

But even if the shorter is right, it doesnt matter. NTI just doesnt have the scope right now to compete.
In fact they are hedging all revenue on NDIS. Don't get me wrong, I have NTI options.

But to compare the two is ridiculous. It would take NTI US$300mil to catch up, and probably 5 years.
If you want NTI at something like $1.6 bil it's going to need a takeover. I don't think TGA approval will cut it in that regard.